CalciMedica CALC
NASDAQ CALC
$0.57 -0.01 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

CalciMedica (CALC) Net Margin (2024 - 2026)

CalciMedica's (CALC) quarterly Net Margin came in at 2784.04% in Q1 2026, down 5025.0% YoY from 56.53% in Q1 2025, and up 2.85% on a QoQ basis from 2706.9% in Q4 2025.

CalciMedica (CALC) Net Margin (2024 - 2026) Analysis & Trends

CalciMedica (CALC) has 3 years of Net Margin data on file, last reported at 2784.04% in Q1 2026.

  • Quarterly Net Margin fell 5025.0% year-over-year to 2784.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 762.95% (down 65798.0% YoY) and the FY2025 annual result came in at 125.92%, up 11026.0% from the prior year.
  • Net Margin climbed to 2784.04% in Q1 2026, from 2706.9% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6677.88% in Q2 2025 to a low of 1989.72% in Q4 2024.
  • A 3-year average of 1653.53% and a median of 1071.54% in 2024 frame the typical range for Net Margin.
  • The widest YoY moves for Net Margin: up 560634 bps in 2025, down 23421 bps in 2025.
  • Tracing CALC's Net Margin over 3 years: stood at 1989.72% in 2024, then soared by 236 bps to 2706.9% in 2025, then gained by 3 bps to 2784.04% in 2026.
  • The last three Net Margin figures came in at 2784.04% (Q1 2026), 2706.9% (Q4 2025), and 294.79% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 31.16%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.51%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 CalciMedica 9.80 Mn -8.82 Mn - 1,600.37%

Historic Data

Download Data
DateValue
Jun 30, 2026 1,600.37%
Mar 31, 2026 2,784.04%
Dec 31, 2025 2,706.90%
Sep 30, 2025 294.79%
Jun 30, 2025 6,677.88%
Mar 31, 2025 2,834.29%
Dec 31, 2024 -1,989.72%
Sep 30, 2024 529.00%
Jun 30, 2024 1,071.54%
Mar 31, 2024 -26.92%